U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H22N2O
Molecular Weight 294.3908
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of VINBURNINE

SMILES

CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)C(=O)C2

InChI

InChIKey=WYJAPUKIYAZSEM-MOPGFXCFSA-N
InChI=1S/C19H22N2O/c1-2-19-9-5-10-20-11-8-14-13-6-3-4-7-15(13)21(16(22)12-19)17(14)18(19)20/h3-4,6-7,18H,2,5,8-12H2,1H3/t18-,19+/m1/s1

HIDE SMILES / InChI

Molecular Formula C19H22N2O
Molecular Weight 294.3908
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Vinburnine is a nutritional product, a peripheral vasodilator with cerebral activities that also act as a cerebral metabolic stimulant and appears to be able to relax the smooth muscle cells within the walls of blood vessels. (+/-)-Eburnamonine is the racemate of the alkaloid Vinburnine. Dextrorotatory, levorotatory, and racemic forms of eburnamonine exist in nature. The (-)-form, also known as vincamone (isolated from Vinca minor), is a drug that possesses a stimulating activity for muscle and is used as cerebrotonic, whereas both enantiomers have hypotensive effects.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P08172
Gene ID: 1129.0
Gene Symbol: CHRM2
Target Organism: Homo sapiens (Human)
68.9 µM [Kd]
Target ID: P11229
Gene ID: 1128.0
Gene Symbol: CHRM1
Target Organism: Homo sapiens (Human)
7.54 µM [Kd]
Target ID: P20309
Gene ID: 1131.0
Gene Symbol: CHRM3
Target Organism: Homo sapiens (Human)
6.67 µM [Kd]
Target ID: P08173
Gene ID: 1132.0
Gene Symbol: CHRM4
Target Organism: Homo sapiens (Human)
23.7 µM [Kd]
Target ID: acetylcholine neurotransmission
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
CERVOXAN

Approved Use

Cerebrovascular diseases
PubMed

PubMed

TitleDatePubMed
Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors.
1997-07
Metabolism of vincamine in the rat in vivo and in vitro.
1980
GENERAL METHODS OF SYNTHESIS OF INDOLE ALKALOIDS. IV. A SYNTHESIS OF DL-EBURNAMONINE.
1965-04-05
Patents

Sample Use Guides

The recommended dosage is 60 mg taken twice a day.
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: Different concentrations of the drugs: vincamine, vinpocetine and eburnamonine (VINBURNINE) (4, 20 and 100 µM) induced minimal stimulation of the ATPase activity of the Bcrp and Pgp membrane transporters. The relative metabolic stability of eburnamonine compared to the other alkaloids suggests the use of eburnamonine or its derivatives as lead compounds for the development of antitumor and nootropic agents that need to cross the BBB and produce their pharmacological effects in the CNS.
Unknown
Substance Class Chemical
Created
by admin
on Wed Apr 02 09:29:24 GMT 2025
Edited
by admin
on Wed Apr 02 09:29:24 GMT 2025
Record UNII
G54D0HMY25
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VINBURNINE
INN   MART.   WHO-DD  
INN  
Official Name English
EBURNAMONINE (-)-FORM
MI  
Preferred Name English
3.ALPHA.,16.ALPHA.-EBURNAMONINE
Common Name English
EBURNAMONINE (-)-FORM [MI]
Common Name English
Vinburnine [WHO-DD]
Common Name English
VINBURNINE [MART.]
Common Name English
NSC-322920
Code English
vinburnine [INN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C932
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
WHO-VATC QC04AX17
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
NCI_THESAURUS C29707
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
WHO-ATC C04AX17
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C152880
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
NSC
322920
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
FDA UNII
G54D0HMY25
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
DRUG BANK
DB13793
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
ChEMBL
CHEMBL1892145
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
RXCUI
57954
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY RxNorm
CAS
4880-88-0
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
MESH
C016422
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
INN
4976
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
EVMPD
SUB00053MIG
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
DRUG CENTRAL
2824
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
ECHA (EC/EINECS)
225-490-5
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
PUBCHEM
71203
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
MERCK INDEX
m4804
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY Merck Index
SMS_ID
100000079106
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
EPA CompTox
DTXSID6045119
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
WIKIPEDIA
VINBURNINE
Created by admin on Wed Apr 02 09:29:24 GMT 2025 , Edited by admin on Wed Apr 02 09:29:24 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY